Literature DB >> 32490128

Chylothorax caused by blunt trauma: Case review and management proposal.

Brandon T Bacon1,2, Wayne Mashas2.   

Abstract

Chylothorax is a potentially devastating complication of lymphatic trauma of the thorax. To date, no recommendations have provided decision making support for prompt definitive treatment. We present a 53 year old male involved in a motor vehicle collision sustaining 9 left rib fractures with flail segments. He was treated non-operatively with a chest tube and no fat diet. A Case report review was performed and a proposed guideline for managing blunt trauma chylothorax in adult patients was developed. In low-output chylothorax, effective initial treatment begins with a no fat diet and chest tube. We propose that a low output leak be defined as <500 mL of initial output or <500 mL/day and can be managed non-operatively in nearly 100% of patients. High output injuries of >1000 mL of initial output will require surgical intervention and should be considered for prompt definitive care.
© 2020 The Authors.

Entities:  

Keywords:  Blunt force trauma; Chest trauma; Chest tube; Chylothorax

Year:  2020        PMID: 32490128      PMCID: PMC7256325          DOI: 10.1016/j.tcr.2020.100308

Source DB:  PubMed          Journal:  Trauma Case Rep        ISSN: 2352-6440


Introduction

Chylothorax is the result of disruption, usually injury, to the lymphatic system in the thoracic cavity resulting in the accumulation of chyle in the pleural spaces. There are several etiologies for this phenomenon, the rarest being blunt trauma at approximately 0.2–3% of cases [1,2]. Chylothorax is confirmed diagnostically with analysis of chest effluent [3,5]. Leakage into the chest cavity presents several problems. First, the lymphatic system produces 1.5–2.5 L daily of chyle which can cause a tension chylothorax. Hydrostatic tension in the thorax can lead to cardiopulmonary collapse with subsequent hemodynamic instability. Second, severe nutritional and electrolyte derangements arise from loss of chyle [3]. Third, chyle contains a significant amount of T cells and immunoglobulins. Loss of this fluid into the chest may result in immunologic depletion and higher risk for systemic infections [3,4,11]. Non-operative traumatic chylothorax is rare. Therapeutic guidelines have not been established and experiential recommendations abound. Current literature suggests beginning with conservative therapies such as source control with chest tube placement or thoracentesis, NPO status, TPN, and a medium chain fatty acid diet. More recently, octreotide and somatostatin have mixed results leaning towards benefit [[6], [7], [8], [9], [10]]. Non-operative management is recommended for 2–6 weeks. If conservative therapy fails, procedural or surgical intervention is usually required [[1], [2], [3],5,12].

Case

A 53 year old male was involved in a motor vehicle collision and sustained 9 left rib fractures with flail segments easily seen on chest radiograph and CT scan (see Fig. 1, Fig. 2). A 28F chest tube was placed in the trauma bay upon arrival for hemopneumothorax. Two hundred milliliters of blood was evacuated originally. The patient's respiratory status remained adequate and pain was controlled with a PCA pump. After a 5 day admission in the surgical ICU, he was transferred to the surgery inpatient unit. At that time, thoracostomy output was <200 mL/day.
Fig. 1

Initial chest radiograph.

Fig. 2

CT scan of rib fractures.

Initial chest radiograph. CT scan of rib fractures. After starting an oral diet he was found to have approximately 100 mL of milky hydrophobic effluent. The fluid was analyzed and found to be consistent with the diagnosis of chylothorax. He was placed on a strict no fat diet. Output from his thoracostomy decreased over the course of 3 days until there was no subjectively visible chyle. The chest tube was removed and subsequent chest x-rays confirmed no re-accumulation of pleural effusion. The patient was discharged after ten days. Three month follow-up chest x-rays verified no further leak (Fig. 3).
Fig. 3

Three month follow up chest radiograph.

Three month follow up chest radiograph.

Discussion

Chylothorax is a rare, but potentially devastating disease. Timely effective treatment is imperative to avoid unnecessary morbidity. The decision to treat with non-operative therapies versus surgical intervention has been traditionally based on an escalation model of care at physician discretion. Utilizing timely objective data to guide therapy may improve patient outcomes. The main question of lymphatic duct injury is whether the duct will heal on its own or if it will require ligation. Thirty-two case reports of chylothorax caused by blunt trauma from 1973 to 2017 were published in English and reviewed. Only 15 (18 total patients) cases reported volume output from chest tube or thoracentesis. The initial outputs were reviewed and recorded along with all the interventions used for each patient (Table 1). Patients with an initial output of <500 mL (7 of 18) were treated with non-operative therapies (thoracostomy, modified diet of low or no fat, and/or TPN with medium chain fatty acids). These cases had 100% resolution without further intervention. Out of the 8 patients with initial chest tube output of >1 L, 62.5% (5 of 8) required definitive procedural repair or ligation of the lymphatic duct. The remaining 3 patients with initial output between 500 and 1000 mL had a 66% success rate with non-operative management.
Table 1

Table of case reports that reported volume output of chyle from chylothorax interventions performed with definitive therapy noted.

AuthorYearInitial output (mL/day)TherapiesCurative therapy
Kumar #22013100CT, NPO, TPN, octreotideConservative
Ikonomidis #11998140CT, NPO, TPNConservative
Ikonomidis #21998240CT, NPO, TPNConservative
Sriprasit2017300CT, NPO, TPNConservative
Pakula2011400CT, low fat diet, octreotideModified diet
Kumar #12013500CT, NPO, TPN, octreotideConservative
Kumar #32013500CT, NPO, TPN, octreotideConservative
Silen1995600CT, NPO, low fat diet, TPN, Ductal ligation, fibrin glueDuctal ligation
Townshend2009625CT, NPO, tube feeds via NGTModified diet
Seitelman2012800CT, TPN, low fat dietConservative
Pai19841000CT, Low fat diet, TPN, Ductal ligationDuctal ligation
Breaux19881250CT, NPO, TPNConservative
Idris20161500CT, fat free dietModified diet
Kurklinsky20111500Thoracentesis, NPO, TPN, embolizationDuct embolization
Chamberlain20002500CT, NPO, TPN, ductal ligationDuctal ligation
Lee20173300CT, NPO, TPNDuctal ligation
Lindhorst19981000|300CT, tube feeds, PEEP ventModified diet
Golden19993000–4000CT, NPO, TPN, ductal ligationDuctal ligation
Table of case reports that reported volume output of chyle from chylothorax interventions performed with definitive therapy noted. No guidelines at the critical point of deciding to pursue conservative therapy versus surgical intervention in a timely manner currently exist. From the case report analysis, we developed a therapy algorithm based on low-, moderate-, and high-output chyle leaks (Fig. 4). In low-output settings, a no fat diet was sufficient therapy without need for surgical interventions. High output injuries are less likely to spontaneously resolve with conservative therapy and should be considered for more prompt surgical interventions. Moderate injuries may benefit from conservative therapy. However, if they persist for >2 weeks, procedural intervention should be considered to reduce morbidity. This algorithm suggests non-operative, conservative therapy is effective for the majority of blunt trauma chylothoraces and can assist practitioners in identifying those patients that will benefit from prompt surgical intervention. Further studies are necessary to validate this algorithm.
Fig. 4

Proposal of treatment algorithm.

Proposal of treatment algorithm.

Declaration of competing interest

The authors have no disclosures regarding financial support or conflict of interest.
  12 in total

1.  The role of somatostatin in the treatment of persistent chylothorax in children.

Authors:  Vincenzo Cannizzaro; Bernhard Frey; Vera Bernet-Buettiker
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-24       Impact factor: 4.191

Review 2.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

Review 3.  Chylothorax: aetiology, diagnosis and therapeutic options.

Authors:  Emmet E McGrath; Zoe Blades; Paul B Anderson
Journal:  Respir Med       Date:  2009-09-18       Impact factor: 3.415

4.  Bilateral traumatic chylothorax treated by thoracic duct embolization: a rare treatment for an uncommon problem.

Authors:  Andrew K Kurklinsky; James C McEachen; Jeremy L Friese
Journal:  Vasc Med       Date:  2011-06-27       Impact factor: 3.239

5.  Chylothorax causing reversible T-cell depletion.

Authors:  J R Breaux; C Marks
Journal:  J Trauma       Date:  1988-05

6.  The successful use of octreotide in the treatment of traumatic chylothorax.

Authors:  Annabel J Sharkey; Jagan N Rao
Journal:  Tex Heart Inst J       Date:  2012

Review 7.  Octreotide for the treatment of chylothorax in neonates.

Authors:  Animitra Das; Prakeshkumar S Shah
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

8.  Acute chylothorax in children: selective retention of memory T cells and natural killer cells.

Authors:  Jordan S Orange; Raif S Geha; Francisco A Bonilla
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

Review 9.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

Review 10.  A review of traumatic chylothorax.

Authors:  T G Pillay; B Singh
Journal:  Injury       Date:  2015-12-23       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.